New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2013
09:11 EDTHUM, WCG, UNH, CI, WLP, AET, MOH, DVAHumana falls after CMS proposes 2014 MA rates, peers follow
Humana (HUM) disclosed today that on Friday, February 15, the Centers for Medicare and Medicaid Services announced preliminary 2014 Medicare Advantage benchmark payment rates. CMS has invited public comment on these preliminary rates before releasing final rates on April 1. Humana believes the preliminary base rates included in the CMS notice would result in a mid-single-digit decline in its benchmark payment rates. Humana said it is analyzing all operational avenues available to address the preliminary rates and related impact upon the company's ability to grow both its Medicare membership and its earnings for 2014. Humana noted its management previously expressed confidence in the companyís ability to grow both Medicare membership and earnings for 2014, based upon expectations that the base Medicare Advantage payment rate would be flat to slightly down. Shares of Humana (HUM) are down 10%, or $8.00, to $69.99 in pre-market trading. Other healthcare names are trading lower after the CMS proposed 2014 Medicare Advantage rates, including WellCare (WCG), UnitedHealth (UNH), Cigna (CI), Wellpoint (WLP), Aetna (AET), Molina (MOH), and DaVita (DVA).
News For HUM;WCG;UNH;CI;WLP;AET;MOH;DVA From The Last 14 Days
Check below for free stories on HUM;WCG;UNH;CI;WLP;AET;MOH;DVA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 22, 2014
13:46 EDTHUM, AET, WCG, MOH, CI, WLP, UNHCourt upholds Obamacare subsidies, NY Times says
Subscribe for More Information
10:43 EDTWCG, WLP, UNH, HUM, MOH, AET, CIAppeals court bars subsidies in health care law
A three-judge panel of the D.C. Circuit Court of Appeals struck down part of President Obama's healthcare law by siding today with plaintiffs who argued that the law barred the government from giving subsidies to people in states that chose not to set up their own insurance marketplaces. The appeals court stated, "Because we conclude that the ACA unambiguously restricts the section 36B subsidy to insurance purchased on Exchanges 'established by the State,' we reverse the district court and vacate the IRSís regulation." Twenty-seven states decided against setting up marketplaces, and another nine states partially opted out, according to the Washington Post.
July 21, 2014
11:02 EDTUNHUnitedHealth, Banner Health Network announce collaboration
Subscribe for More Information
10:02 EDTDVAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:43 EDTDVADaVita downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
July 18, 2014
16:47 EDTUNHMarket ends week higher as earnings, M&A offset geopolitical tensions
Subscribe for More Information
16:05 EDTDVADaVita says CEO of HealthCare Partners subsidiary to step down
DaVita HealthCare Partners announced that HealthCare Partners, or HCP, president and CEO Dr. Craig Samitt is stepping down from HCP effective August 1. Kent Thiry, co-chairman and CEO of DaVita HealthCare Partners, will take over the role of CEO of HCP, working in tandem with the office of Chief Medical Officer.
08:45 EDTUNHUnitedHealth price target raised to $94 from $84 at Oppenheimer
Subscribe for More Information
July 17, 2014
16:52 EDTUNHOn The Fly: Closing Wrap
Subscribe for More Information
13:18 EDTUNHOn The Fly: Midday Wrap
Subscribe for More Information
09:13 EDTUNHUnitedHealth expects improving environment in 2016 and beyond
Expects to expand up to two dozen state exchanges in 2014. Project 6% commercial medical cost trend for 2016, with costs in line with company's plan and remains moderate. Expects margins to reach 7% this year, in line with original forecast. Expects Optum revenue to accelerate in 2H14, and particularly in Q4. Comments taken from Q2 earnings conference call.
07:00 EDTDVAFresenius Medical shares should be bought, says Bernstein
Bernstein notes that Fresenius' (FMS) stock has sharply underperformed versus its competitor, DaVita (DVA), since May 2012. But the firm predicts that Fresenius' core U.S. business should outperform that of DaVita going forward. Bernstein adds that it finds Fresenius' business units aside from its U.S. dialysis clinics more attractive than DaVita's businesses other than its U.S. dialysis clinics.
06:18 EDTUNHUnitedHealth reports Q2 Optum revenue $11.7B
Subscribe for More Information
06:18 EDTUNHUnitedHealth raises low end of FY14 EPS to $5.50-$5.60 from $5.40-$5.60
Subscribe for More Information
06:18 EDTUNHUnitedHealth reports Q2 EPS $1.42, consensus $1.26
Reports Q2 revenue $32.57B, consensus $32B
July 16, 2014
15:27 EDTUNHNotable companies reporting before tomorrow's open
Subscribe for More Information
14:32 EDTUNHUnitedHealth July 84 straddle priced for 2.8% move into Q2
July 14, 2014
16:15 EDTHUMHumana, Tenet sign new multi-year national agreement
Subscribe for More Information
09:23 EDTWLPWellPoint Q2 EPS likely to beat consensus by 55c, says Sterne Agee
Subscribe for More Information
07:22 EDTHUM, MOH, WLPHealthcare Education Associates to hold a conference
4th Annual RISE California Summit to be held in San Diego on July 13-15.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use